adampearce

31 POSTS 0 COMMENTS

Canadian Association for Interventional Radiology names Tara Graham as new president

Tara Graham (Trillium Health Partners, Toronto, Canada) has become the new president of the Canadian Association for Interventional Radiology (CAIR), assuming the new role...

Scitech Medical’s Embosoft microspheres receive CE mark approval for vascular embolization

Scitech Medical, has announced that it has received CE mark approval for the Embosoft microspheres for use in vascular embolization of hypervascular tumours, symptomatic...

CAVA RCT sets stage for pivot to PORTs as central venous...

CAVA
 The CAVA (Central venous access devices for the delivery of systemic anticancer therapy) randomised controlled trial (RCT), just published in The Lancet, has revealed...

Episode 3: The unique recipe for long-term clinical benefit with IN.PACT™...

In this third episode of a special five-part series on the history of DCBs, Jos van den Berg (Lugano, Switzerland) moderates a Interventional News roundtable...

Imaging, precise tools, in-procedure ablation zone visibility and confirmation of success...

Constantinos Sofocleous (New York, USA) sits down with Interventional News to discuss how image-guided thermal ablation, when it is deployed with an intent to...

How it’s made: Interlock and IDC Detachable Coils

NOTE: This video is ONLY available to watch in selected countries and geographies In case of embolisation, Interlock and IDC Detachable Coils (Boston Scientific)...

IN.PACT™ AV Access trial demonstrates “outstanding” patency rates & “significant” advantages...

 Andrew Holden (Auckland, New Zealand) presents the latest results from the IN.PACT™ AV Access trial (Medtronic), which indicate “outstanding” target-lesion primary patency rates of 52.2% through 24...

Why histotripsy may be the next leap forward in ablative therapy

 Histotripsy, which was invented at the University of Michigan, uses pulsed sound waves to destroy tissue. It is a non-invasive and non-thermal mechanism that...

Episode 2: Are all peripheral drug-coated balloons created equal?

 “Not all Drug-Coated Balloons (DCBs) are created equal”, Juan Granada (New York, USA), tells Vascular News in this second episode of a five-part series on the history of DCBs. Granada discusses why there are...

Episode 2: Are all peripheral drug-coated balloons created equal?

 “Not all Drug-Coated Balloons (DCBs) are created equal”, Juan Granada (New York, USA), tells Vascular News in this second episode of a four-part series on the history of DCBs. Granada discusses why there...

Episode 1: Luminor DCB in the femoropopliteal segment: Outstanding safety and...

NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Episode 2: Experience of Luminor DCB in the below-the-knee segment

NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Episode 3: Not all DCBs are the same: Luminor TransferTech nanotechnology...

NOTE: This video is ONLY available to watch in selected countries and geographies  Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...

Bringing 3D into the lab: SmartCT, the next-generation imaging system

 Constantino Peña (Miami, USA) moderates an Interventional News webinar focusing on how the SmartCT system (Philips) can “transform” IR suites and the importance of...

Trialists’ insights on the 2-year results from the COMPARE trial

NOTE: This video is ONLY available to watch in selected countries and geographies  Sabine Steiner (Leipzig, Germany) sits down with Michael Jaff, the CMO...

SIR 2021 Abstract of the Year: OPuS One data “should move...

NOTE: This video is ONLY available to watch in selected countries and geographies  Jason Levy (Atlanta, USA) and Elizabeth David (Toronto, Canada) talk to Interventional...

SIR 2021 president underscores COVID-19, diversity and the value of image-guided...

Interventional radiologists were often at the frontlines, doing remarkably large numbers of procedures treating COVID-19 patients and among the only specialties that carried on...

The reluctant cowboy takes aim at a fistful of IR myths

The adrenaline-rush of seeing or doing an elegant procedure that can alter the course of a patient’s life is often the career-inspiring doorway into...

“You have to help the next woman up”: Highlighting pioneering women...

 President of the American College of Radiology (ACR), Geraldine McGinty is also a radiologist and the chief strategy officer, as well as the chief...

Episode 1: Go behind the scenes to delve into the birth...

 To mark the 20-year anniversary of drug-coated balloons, Bruno Scheller (Homburg/Saar, Germany) and Gunnar Tepe (Rosenheim, Germany), talk to Vascular News about their contributions...

Go behind the scenes to delve into the birth and evolution...

To mark the 20-year anniversary of drug-coated balloons, Bruno Scheller (Homburg/Saar, Germany) and Gunnar Tepe (Rosenheim, Germany), talk to Vascular News about their contributions...

‘Indisputable evidence’ that DCB is the “gold standard” for treating vascular...

NOTE: This video is ONLY available to watch in selected countries and geographies Tobias Steinke (Düsseldorf, Germany), Matteo Tozzi (Varese, Italy) and Robert Shahverdyan...

CONSEQUENT study shows low mortality and TLR rates in PAD patients...

NOTE: This video is ONLY available to watch in selected countries and geographies Ralf Langhoff (Berlin, Germany) talks to Vascular News about the 12-month...

24-month AVeNEW data show significantly better target lesion patency of Covera™...

Bart Dolmatch (Portola Valley, USA) talks to Vascular News about some of the key data highlights from the 24-month AVeNEW trial, which compared the safety and efficacy...

The perils of positive news filters, and silent, dangerous revolution of...

“Not everything that is published is true or important” and “always be critical, but not cynical,” urges Jim Reekers, editor-in-chief of CVIR Endovascular, as...

How a personal experience of contracting COVID-19 as a healthcare professional...

Felipe Nasser (São Paulo, Brazil) talks to Interventional News about his experience of the COVID-19 pandemic after contracting the SARS-CoV-2 virus himself, saying that the infection and period of isolation “made me think...

DISRUPT PAD III results and how they fit into the endovascular...

Moderate-to-severe calcification in peripheral arteries is an “ongoing battle” in in the endovascular treatment of complex lesions, William Gray (Philadelphia, USA), tells Vascular News. Gray explains that there are...

Philips launches QuickClear mechanical thrombectomy system for blood clot removal in...

Royal Philips has announced the launch of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove...

Siemens Healthineers agrees to acquire Varian in US$16.4 billion deal

Siemens Healthineers has announced it has reached an agreement to acquire Varian Medical Systems, a US company active in the area of cancer research...

Early experience shows Caterpillar™ embolization device can be accurately deployed and...

NOTE: This video is ONLY available to watch in selected countries and geographies Ripal Gandhi (Miami, USA) outlines his initial experiences with the Caterpillar™ Arterial Embolization Device (BD), a product, which he...

Real-world data with long-term follow-up confirm no increased mortality signal with...

Data from an unselected, real-world cohort of 64,000 claimants of the German BARMER Health Insurance reveals no signal of increased long-term mortality when paclitaxel-based...